252 related articles for article (PubMed ID: 36803784)
1. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.
Sheng G; Gao Y; Ding Q; Zhang R; Wang T; Jing S; Zhao H; Ma T; Wu H; Yang Y
J Transl Med; 2023 Feb; 21(1):132. PubMed ID: 36803784
[TBL] [Abstract][Full Text] [Related]
2. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
[TBL] [Abstract][Full Text] [Related]
3. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
4. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.
Shen S; Yao T; Xu Y; Zhang D; Fan S; Ma J
Mol Cancer; 2020 Oct; 19(1):151. PubMed ID: 33106166
[TBL] [Abstract][Full Text] [Related]
5. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
Sheng G; Gao Y; Wu H; Liu Y; Yang Y
J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
[TBL] [Abstract][Full Text] [Related]
6. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
7. miR‑193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma.
Gao J; Ma S; Yang F; Chen X; Wang W; Zhang J; Li Y; Wang T; Shan L
Oncol Rep; 2020 Jul; 44(1):139-155. PubMed ID: 32377743
[TBL] [Abstract][Full Text] [Related]
8. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
9. PDGFRβ modulates aerobic glycolysis in osteosarcoma HOS cells via the PI3K/AKT/mTOR/c-Myc pathway.
Tang HY; Guo JQ; Sang BT; Cheng JN; Wu XM
Biochem Cell Biol; 2022 Feb; 100(1):75-84. PubMed ID: 34678088
[TBL] [Abstract][Full Text] [Related]
10. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
Yang Y; Fei M; Zhou X; Li Y; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
[No Abstract] [Full Text] [Related]
11. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
[TBL] [Abstract][Full Text] [Related]
12. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
[TBL] [Abstract][Full Text] [Related]
13. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway.
Fan Y; Jia X; Xie T; Zhu L; He F
Oncol Rep; 2020 Dec; 44(6):2669-2677. PubMed ID: 33125136
[TBL] [Abstract][Full Text] [Related]
15. Baicalein suppresses the viability of MG-63 osteosarcoma cells through inhibiting c-MYC expression via Wnt signaling pathway.
He N; Zhang Z
Mol Cell Biochem; 2015 Jul; 405(1-2):187-96. PubMed ID: 25893737
[TBL] [Abstract][Full Text] [Related]
16. A newly synthesized oleanolic acid derivative inhibits the growth of osteosarcoma cells in vitro and in vivo by decreasing c-MYC-dependent glycolysis.
Gao F; Zuo Q; Jiang T; Song H; Zhou J
J Cell Biochem; 2019 Jun; 120(6):9264-9276. PubMed ID: 30552712
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.
Xu N; Li Z; Yu Z; Yan F; Liu Y; Lu X; Yang W
PLoS One; 2014; 9(12):e115300. PubMed ID: 25546234
[TBL] [Abstract][Full Text] [Related]
18. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
19. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression.
Gamberi G; Benassi MS; Bohling T; Ragazzini P; Molendini L; Sollazzo MR; Pompetti F; Merli M; Magagnoli G; Balladelli A; Picci P
Oncology; 1998; 55(6):556-63. PubMed ID: 9778623
[TBL] [Abstract][Full Text] [Related]
20. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma.
Zheng D; Liu W; Xie W; Huang G; Jiang Q; Yang Y; Huang J; Xing Z; Yuan M; Wei M; Li Y; Yin J; Shen J; Shi Z
Signal Transduct Target Ther; 2021 Jan; 6(1):25. PubMed ID: 33468990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
